Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice

British Journal of Haematology

Volumn 94, Issue 1, 1996, Pages 53-61

  Dedera, Douglas A ^a   Urashima, Mitsuyoshi ^a   Chauhan, Dharminder ^a   LeBrun, David P ^b   Bronson, Roderick T ^c   Anderson, Kenneth C ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c TUFTS UNIVERSITY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Interleukin 6; Interleukin 6 knockout mice; Plasmacytoma; Plasmacytosis; Pristane

Indexed keywords

INTERLEUKIN 6; PRISTANE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPERPLASIA; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPH NODE; MOUSE; NONHUMAN; PLASMACYTOMA; PLASMACYTOSIS; PRIORITY JOURNAL; SPLEEN;

EID: 0030036384     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.6282074.x     Document Type: Article

References (48)

1. Akira, T., Taga, T. & Kishimoto, T. (1993) Interleukin-6 in biology and medicine. Advances in Immunology, 54, 1-78.
2. Anderson, K.C., Bates, M.P., Slaughenhoupt, B.L., Pinkus, G.S., Schlossman, S.F. & Nadler, L.M. (1984) Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood, 63, 1424-1433.
3. Anderson, K.C., Boyd, A.W., Fisher, D.C., Slaughenhoupt, B., Groopman, J.E., O'Hara, C.J., Daley, J.F., Schlossman, S.F. & Nadler, L.M. (1985) Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2-subsets. Journal of Immunology, 134, 820-827.
4. Anderson, K.C., Morimoto, C., Paul, S.R., Chauhan, D., Williams, D., Cochran, M. & Barut, B.A. (1992) Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood, 80, 2797-2804.
5. Anderson, P.N. & Potter, M. (1969) Induction of plasma cell tumours in Balb/c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature, 222, 994-995.
6. Armitage, R.J., MacDuff, B.M., Spriggs, M.K., & Fanslow, W.C. (1993) Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. Journal of Immunology, 150, 3671-3680.
7. Beecham, E.J., Mushinski, J.F., Shacter, E., Potter, M. & Bohr, V.A. (1991) DNA repair in the c-myc proto-oncogene locus: possible involvement in susceptibility or resistance to plasmacytoma induction in BALB/c mice. Molecular and Cellular Biology. 11, 3095-3104.
8. Bergsagel, P.L., Brents, L.A., Trepel, J.B. & Kuehl, W.M. (1995) Genes expressed selectively in murine and human plasma cell neoplasms. Current Topics in Microbiology and Immunology, 194, 57-61.
9. Bergsagel, P.L., Timblin, C.R., Eckhardt, L., Laskov, R. & Kuehl, W.M. (1992) Sequence and expression of a murine cDNA encoding PC326, a novel gene expressed in plasmacytomas but not normal plasma cells. Oncogene, 7, 2059-2064.
10. Bernad, A., Kopf, M, Kulbacki, R., Weich, N., Koehler, G. & Gutierrez-Ramos, J.C. (1994) Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity, 1, 725-731.
11. Chauhan, D., Kharbanda, S., Uchiyama, H., Urashima, M., Fragosa, R., Sen, J., Kufe, D.W. & Anderson, K.C. (1994) Identification of upstream signals regulating interleukin-6 gene expression during in vitro treatment of human B cells with pokeweed mitogen. Blood, 84, 2243-2252.
12. Cleary, M.L., Smith, S.D. & Sklar, J. (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47, 19-28.
13. Dalrymple, S.A., Lucian, L.A., Slattery, R., McNeil, T., Aud, D.M., Fuchino, S., Lee, F. & Murray, R. (1995) Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infection and Immunity, 63, 2262-2268.
14. Early, P., Rogers, J., Davis, M., Calame, K., Bond, M., Wall, R. & Hood, L. (1980) Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways. Cell, 20, 313-319.
15. Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L, Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P. & Poli, V. (1994) Defective inflammatory response in interleukin-6 deficient mice. Journal of Experimental Medicine, 180, 1243-1250.
16. Freeman, G.J., Freedman, A.S., Rabinowe, S.N., Segil, J.M., Horowitz, J., Rosen, K., Whitman, J.F. & Nadler, L.M. (1989) Interleukin-6 gene expression in normal and neoplastic B cells. Journal of Clinical Investigation, 83, 1512-1518.
17. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H. & Epstein, J. (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood, 84, 3063-3070.
18. Hilbert, D.M., Kopf, M., Mock, B.A., Kohler, G. & Rudikoff, S. (1995) Interleukin-6 is essential for in vivo development of B lineage neoplasms. Journal of Experimental Medicine, 182, 243-248.
19. Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K.H. & Kishimoto, T. (1985) Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSFp-2). Proceedings of the National Academy of Sciences of the United States of America. 82, 5490-5494.
20. Horii, Y., Muraguchi, A., Suematsu, S., Matsuda, T., Yoshizaki, K., Hirano, T. & Kishimoto, T. (1988) Regulation of BSF-2/IL-6 production by human mononuclear cells. Journal of Immunology, 141, 1529-1535.
21. Jabara, H.H., Fu S.M., Geha R.S. & Vercelli D. (1990) CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. Journal of Experimental Medicine, 172, 1861-1864.
22. Jalkanen, M., Nguyen, H., Rapraeger, A., Kurm, N. & Bernfield, M. (1985) Heparin sulfate proteoglycans from mouse mammary epithelial cells: localization on cell surface with a monoclonal antibody. Journal of Cellular Biology, 101, 976-984.
23. Janz, S., Müller, J., Shaughnessy, J. & Potter, M. (1993) Detection of recombinations between c-myc and immunoglobulin switch α in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. Proceedings of the National Academy of Sciences of the United States of America, 90, 7361-7365.
24. Kawano, M.M., Mihara, K., Huang, N. Tsujimoto, T. & Kuramoto, A. (1995) Differentiation of early plasma cells on bone marrow stromal cells requires IL-6 for escaping apoptosis. Blood, 85, 487-494.
25. Kehrl, J.H., Roberts, A.B., Wakefield, L.M., Jakowlew, S., Sporn, M.B. & Fauci, A.F. (1986) Transforming growth factor β is an important immunoregulatory protein for human B lymphocytes. Journal of Immunology, 137, 3855-3860.
26. Klein, B., Zhang, X.G., Yang, L.Z. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
27. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. & Kohler, G. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature, 368, 339-342.
28. Matsushima, K., Procopio, A., Abe, H., Scala, G., Ortaldo, J.R. & Oppenheim, J.J. (1985) Production of interleukin-1 activity by normal human peripheral blood B lymphocytes. Journal of Immunology, 135, 1132-1136.
29. Matthes, T., Werner-Favre, C., Tang, H., Zhang, X., Kindler, V. & Zubler, R.H. (1993) Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor α, interleukin(IL)-6, IL-10, and transforming growth factor β1 mRNAs. Journal of Experimental Medicine, 178, 521-528.
30. Morse, H.C., II, Riblet, C.R., Asofsky, R. & Weigert, M. (1978) Plasmacytomas of the NZB mouse. Journal of Immunology, 121, 1969-1972.
31. Muller, J.R., Potter, M. & Janz, S. (1994) Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells. Proceedings of the National Academy of Sciences of the United States of America, 91, 12066-12070.
32. Muraguchi, A., Nishimoto, H., Kawamura, N., Hori, A. & Kishimoto, T. (1986) B-cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes. Journal of Immunology, 137, 179-186.
33. Nordan, R.P., Pumphrey, J.G. & Rudikoff, S. (1987) Purification and NH-2 terminal sequence of a plamacytoma growth factor derived from the murine macrophage cell line P388D1. Journal of Immunology, 139, 813-817.
34. Potter, M. & Boyce, C.R. (1962) Induction of plasma cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature, 193, 1086-1087.
35. Potter, M., Mushinski, E.B., Wax, J.S., Hartley, J. & Mock, B.A. (1994) Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Research, 54, 969-975.
36. Potter, M.J., Pumphrey, J.G. & Bailey, D.W. (1975) Genetics of susceptibility of plasmacytoma induction. I. Balb/cAnN (C), C57B1/6N (B6), C57B1/Ka (BK), (C × B6)F1, (C × BK)F1, and C × B recombinant-inbred strains. Journal of the National Cancer Institute, 54, 1413-1417.
37. Potter, M. & Wax, J.S. (1983) Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens. Journal of the National Cancer Institute, 71, 391-395.
38. Potter, M., Wax, J.S. & Blankenhorn, E. (1985) Balb/c subline differences in susceptibility to plasmacytoma induction. Current Topics in Microbiology and Immunology, 122, 234-241.
39. Rich, B.E., Campos-Torres, J., Tepper, R.I., Moreadith, R.W. & Leder, P. (1993) Cutaneous lymphoproliferation and lymphomas in interleukin-7 transgenic mice. Journal of Experimental Medicine, 177, 305-316.
40. Rico-Vargas, S.A., Potter, M. & Osmond, D.G. (1995) Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Journal of Immunology, 154, 2082-2091.
41. Schwarze, M.M. & Hawley, R.G. (1995) Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-x1. Cancer Research, 55, 2262-2265.
42. Spriggs, M.K., Armitage, R.J., Strockbine, L., Clifford, K.N., Macduff, B.M., Sato, T.A., Sato, T.A., Maliszewski, C.R. & Fanslow, W.C. (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. Journal of Experimental Medicine, 176, 1543-1550.
43. Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T. & Kishimoto, T. (1989) IgG1 plasmacytosis in interleukin 6 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 86, 7547-7551.
44. Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T. & Kishimoto, T. (1992) Generation of plamacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 89, 232-235.
45. Uckun, F.M. (1990) Regulation of human B cell ontogeny. Blood, 76, 1908-1923.
46. Urashima, M., Chauhan, D., Hatziyanni, M., Ogata, A., Hollenbaugh, D., Aruffo, A. & Anderson, K.C. (1996) CD40 ligand triggers interleukin-6 mediated B cell differentiation. Leukemia Research (in press).
47. Van Damme, J.V., Opdenakker, G., Simpson, R.J., Rubira, M.R., Cayphas, S., Vink, A., Billiau, A. & Van Snick, J. (1987) Identification of the human 26-kd protein, Interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. Journal of Experimental Medicine, 165, 914-919.
48. Van Snick, J., Cayphas, S., Vink, A., Uyttenhove, C., Coulie, P.G., Rubira, M.R. & Simpson, R.J. (1986) Purification and NH-2 terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proceedings of the National Academy of Sciences of the United States of America, 83, 9679-9683.